PDX INSIGHTS
PIONEERING CANCER RESEARCH
Model Details

Patient Information for Model: TCCC-OS54

Model Contact
Model: TCCC-OS54
Model Contact: Nino Rainusso
Institution: TCH Sarcoma PDX Program
Email: ncrainuss@texaschildrens.org

Patient Information
Clinical Timeline


Clinical Information at Collection
Clinical Biomarkers/Mutations
Pathology Information at Collection

Model Information for Model: TCCC-OS54

Model Details - Initial Implantation of Patient Tissue
Mutations (Cancer Gene Census List)
Mutation data is currently not available.

CNV
There are no omics data for this model.


Histology Information for Model: TCCC-OS54
There are no histology images for this model.













Metastasis Information for Model: TCCC-OS54
 
Patient
PDX
Bone
Lung

Patient Treatment Information for Model: TCCC-OS54

Event IdTreatmentTreatment SettingAge at StartAge at EndDurationClinical ResponsePathologic ResponseReason Stopped
10Methotrexate, Doxorubicin, CisplatinNeoadjuvant18.1618.5124 daysProgress on chemotherapyPoor response (45% tumor necrosis) Surgical resection (local control)
20Ifosfamide /EtoposideAdjuvant18.519.0183 daysProgress on chemotherapyProgression of disease
30Investigational agent /PalliativeAdjuvant19.019.2591 daysProgress on therapyProgression of disease, died













Please wait...